Tesamorelin Dosage: A Beginner's Guide to Amounts and Timing

Built by medical professionals, gym rats, and experienced biohackers

Tesamorelin is most often discussed at a once-daily dose of around 1 to 2 mg, injected subcutaneously, usually in the evening. The clinical approval for Egrifta (the pharmaceutical form) used 2 mg per day in specific patient populations. These figures are starting points for research, not personal prescriptions.

What Is Tesamorelin and How Does It Work?

Tesamorelin is a synthetic analog of growth hormone releasing hormone (GHRH). Rather than supplying growth hormone directly, it signals the pituitary gland to produce and release the body's own growth hormone.

This indirect mechanism is one reason it gets so much attention in research communities. The body still controls the actual release, so the pulse pattern stays closer to natural compared to direct growth hormone administration.

Tesamorelin has a documented clinical history. It received FDA approval under the brand name Egrifta for reducing excess visceral abdominal fat in adults with HIV-associated lipodystrophy. Outside that approved use, it is sold as a research compound, and general-population safety data is much more limited.

What Dose Is Commonly Discussed for Tesamorelin?

The most commonly referenced figure in research and biohacker communities is 1 to 2 mg per day, injected subcutaneously.

The FDA-approved clinical protocol used 2 mg once daily in the lipodystrophy studies. Community users often start at 1 mg to gauge tolerance before moving up.

A few things to keep in mind about these numbers:

They come from specific study populations or community self-reporting, not universal guidelines.
Individual response varies based on age, body composition, existing hormone levels, and other factors.
"Commonly cited" does not mean "right for you." A clinician familiar with peptides is the right person to help set an individual number.

Treat any dose figure as a research reference. Log everything so you have a real record of what you used and when.

Why Do People Choose Once-Daily Dosing?

Tesamorelin has a short half-life, estimated at roughly 26 minutes in circulation. Despite that, once-daily dosing was the protocol used in the clinical approval studies, and the downstream effect on growth hormone and IGF-1 levels lasted through a 24-hour cycle.

This makes practical sense for most people. One injection per day is easier to track, easier to keep consistent, and easier to log accurately. Consistency matters more than precision timing for most reported outcomes in the research literature.

Some advanced users split doses, but there is no strong published evidence that twice-daily administration improves outcomes compared to once daily in the approved-use research.

Why Does Nighttime Timing Come Up So Often?

Growth hormone secretion follows a circadian rhythm. The largest natural pulse happens during slow-wave sleep, typically in the first few hours after falling asleep.

Because tesamorelin works by amplifying the body's own release, dosing close to bedtime is thought to stack with that natural pulse rather than work against it. This reasoning shows up consistently in both clinical discussions and community forums.

That said, direct evidence comparing evening versus morning tesamorelin dosing in humans is limited. The nighttime preference is logical and widely practiced, but it is not a hard rule backed by large controlled trials.

If you are tracking your results carefully, tools like the dose log at DoseVault make it easy to record exact timing each day and spot patterns over weeks.

What Should Beginners Know Before Starting?

A few practical points that come up repeatedly in research contexts:

Start low. Beginning at 1 mg rather than 2 mg lets you observe how your body responds before committing to a higher amount.

Check for contraindications. Clinical trials excluded people with active malignancies, pregnancy, and certain pituitary conditions. People with diabetes, a history of cancer, or other hormone-sensitive conditions should speak with a clinician before using any GHRH analog.

Plan the cycle length. The lipodystrophy trials ran for 26 weeks. Longer cycles, shorter cycles, and on/off protocols are all discussed in community spaces, but head-to-head data comparing them is sparse.

Get labs if possible. Baseline and follow-up IGF-1 measurements give you real data on whether anything is shifting, rather than guessing from how you feel.

How Do You Get the Math Right After Mixing?

Tesamorelin is sold as a lyophilized (freeze-dried) powder and requires reconstitution with bacteriostatic water before use. This is where dosing errors most often happen. The concentration depends entirely on how much water you add, and that number changes the volume you draw for every single dose.

Getting the conversion from milligrams to units on an insulin syringe right matters every time. A reconstitution calculator removes the arithmetic and shows you the exact volume to draw.

The DoseVault app at dosevault.app includes a reconstitution calculator and a daily tracker built specifically for this workflow. Enter your vial size, water volume, and dose, and it returns the syringe units directly.

Frequently Asked Questions

Is 2 mg per day the right dose for everyone?
No. 2 mg was the dose used in the specific FDA-approved clinical setting for HIV lipodystrophy. It is a research reference point, not a universal recommendation.

Does it matter if I inject in the morning instead of evening?
Morning dosing is used by some researchers. Evening is more common because of the sleep-related GH pulse, but direct comparative data in humans is limited.

How long are typical research cycles?
The lipodystrophy trials used 26-week cycles. Community-reported cycles vary widely. There is no universal consensus on optimal cycle length outside the approved indication.

Can I combine tesamorelin with other peptides?
Combination use is discussed in community forums but has almost no controlled clinical data. This is a question for a knowledgeable clinician, not a forum thread.

This article is for general educational purposes only. It does not diagnose, treat, cure, or prevent any condition. Speak with a licensed healthcare professional before using any peptide or research compound.